NASDAQ
Ernexa Therapeutics Inc. (ERNA) has a free cash flow growth of -94.84% as of Friday, May 29, 2026. This represents a 585.42% decrease compared to its 12-month average of 19.54%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.